Sinowise Medical Imaging announced the official completion of a Pre A round of financing of nearly HK$60 million

Launched the Group's brand Aitrasound® and a new AI medical imaging product line

Hong Kong - Media OutReach Newswire - April 26, 2024 - Recently, Zhonghui Medical Imaging Co., Ltd. announced the official completion of the Pre A round of financing of nearly HK$60 million, the Pre A round of financing in March 2023 to complete the first round of nearly HK$40 million, and the successful additional US$2.5 million in the first quarter of this year, the additional investment is led by the AEF Greater Bay Area Venture Fund (managed by the Gobi Greater Bay Area), which will mainly invest in the construction of Internet hospitals and suitable for schools, The digital therapy platform for families has been built to realize the commercial closed-loop integration of screening, diagnosis and treatment.

Sinowise Medical Imaging officially launched its new group brand, Aitrasound®

At present, the company has officially opened the A round of financing, and plans to raise 50 million yuan in the first round for the expansion of the new business model of integrated screening, diagnosis and treatment of musculoskeletal chronic diseases and the development of Aitrasound® AI intelligent 3D ultrasound image diagnosis product line. The A round of financing involves Zhonghui Medical Imaging, which will build a global headquarters base in China, and it is reported that it has already negotiated the details of the landing in the intended city.

At the 89th China International Medical Equipment Fair of Shanghai CMEF on April 11~14, Zhonghui Medical Imaging officially released a new group brand Aitrasound®, opening a new chapter in the company's brand, which will realize AI intelligent 3D ultrasound image diagnosis in more chronic disease fields. The brand name Aitrasound® is inspired by the fusion of AI (Artificial Intelligence) and Ultrasound technologies, and is committed to realizing the vision of "3D medical imaging - anytime, anywhere, anyone and affordable".

Based on the world's first unique technology, 3D ultrasound spine image assessment, Scolioscan®, a brand of Zhonghui Medical Imaging, integrates scoliosis assessment equipment, spinal image processing software and data management cloud platform to launch a complete set of solutions for scoliosis screening, diagnosis and treatment, from large-scale screening to non-surgical intervention, to achieve zero-radiation, high-precision medical quantitative assessment, and make specialized screening and diagnosis more accurate.

According to the 2022 flow survey data compiled by the Spine Disease Prevention and Control Committee of the Chinese Preventive Medicine Association, the prevalence of scoliosis in adolescents is now as high as 3%~5%. The vast majority of patients appear normal in appearance and are prone to miss the optimal period of treatment, and timely detection of the disease can help maximize the outcome of recovery. Screening practices in many places have proved that Scolioscan's® rapid and accurate screening program has greatly improved the economic benefits and feasibility of school screening activities, making diagnosis safer and more convenient, and escorting the spinal health of adolescents.

With the inclusion of spinal health check-ups in primary and secondary school students, cognitive enhancement has brought about a demand for treatment. With the rapid growth of the demand for spinal rehabilitation, Scolioscan® is aware of the changes in the treatment stage, and the safe and radiation-free scanning method meets the clinical needs of frequent testing, which helps doctors and patients to check the progress of the disease at any time and obtain timely treatment feedback.

Innovative imagery, more exciting. Ultrasound is a high-frequency sound wave that penetrates the skin, tissues, and fluids and is reflected back by the interface of organs and structures to form an image that can be used by doctors to diagnose and treat diseases. Zhonghui Medical Imaging originated from the 3D ultrasound imaging technology independently developed by the Biomedical Engineering Laboratory of the Hong Kong Polytechnic University, adding artificial intelligence algorithms on the basis of ultrasound, breaking the traditional limitations of ultrasound and realizing subversive 3D ultrasound bone imaging. In addition to spinal diseases, muscle, ligament, bone and joint injuries and other diseases throughout the human body can also be accurately assessed through three-dimensional imaging, which is convenient and fast, opening a green channel for diagnosis and treatment. The new generation of musculoskeletal ultrasound products uses new imaging algorithms to perform clinical non-invasive, painless, and radiation-free three-dimensional imaging of the pelvic cavity and limbs, combined with the professional program design of scientific exercise exercises, and patients can undergo rehabilitation training such as poor posture adjustment, exercise intervention for chronic diseases, and some chronic pain intervention under the guidance of the digital therapy APP. Rehabilitation therapy and surgical auxiliary products integrate 3D ultrasound and force sensing technology to guide sports rehabilitation robots, fracture alignment surgery, scoliosis surgery and anesthesia puncture, so that real-time dynamic images are at your fingertips, helping to customize radiation-free precision rehabilitation and minimally invasive surgery programs.

Innovation is the foundation of Zhonghui Medical Imaging, and after more than 20 years of technology research and development and clinical verification, the company continues to break through barriers and expand boundaries. The new brand image carries more visions, and Sinowise Medical Imaging will forge ahead on a broader track and explore medical technology solutions for life and health.

Ms. Han Mingzhu, President of Sinowise Medical Imaging, said, "The launch of the Aitrasound® Group brand marks the upgrade of Sinowise Medical Imaging from an innovative medical device medical technology company to an innovative medical technology service platform integrating chronic disease screening, diagnosis and treatment. Combining the concept of integration of sports and medicine and the treatment experience of traditional Chinese and Western medicine, we provide comprehensive solutions for precision rehabilitation and minimally invasive surgery based on AI + medical imaging technology for medical institutions, schools and families. Through 3D ultrasound medical quantitative evaluation, AI digital rehabilitation, 3D minimally invasive surgery guidance and other programs, medical institutions are empowered to jointly build a characteristic specialist outpatient treatment system. In the next step, we will also set up an Internet hospital, so that assessment and rehabilitation are no longer limited to hospital-specific scenarios, improve patients' autonomy and participation, and integrate treatment into daily life. In terms of global expansion, we will obtain the US FDA Class II medical device certification in the third quarter of 2024 and officially enter the US market. "

Mr. Tang Qibo, Managing Partner of Gobi Ventures, said: "We have been focusing on investing in independent and original technology achievements in the Greater Bay Area for a long time, and continuously expanding application scenarios and markets. As an entrepreneurial team originating in Hong Kong, Zhonghui Medical Imaging combines the independent original technology elements of artificial intelligence, hard technology and big health, and the core team has rich experience in technology commercialization, using localization advantages to expand diversified scenario income sources in China, and building China's independent original technology brand with characteristic products in overseas markets. We empower entrepreneurs from the early stage to the growth stage, focus on emerging industries and markets, and look forward to more outstanding companies based in the Greater Bay Area to the world in the future.

https://www.aitrasound.com/

https://www.linkedin.com/company/aitrasound/

Hashtag: #Aitrasound #中慧医学成像

About Sinowise Medical Imaging

Sinowise Medical Imaging Co., Ltd. is the world's leading provider of 3D ultrasound imaging technology, equipment and solutions.

• Scolioscan® is the world's first and only ultrasound scoliosis assessment system, filling the global technology gap in 3D ultrasound spine imaging, with more than 30 patent clusters and a total of more than 100 patents. The evaluation system has completed clinical tests and put into use in hospitals and clinics in Europe, Australia, Southeast Asia, Chinese mainland and Hong Kong, and has obtained the certification of EU CE, Australian ARTG, Chinese mainland NMPA, Thai FDA, Malaysian MDA and other national Class II medical device certifications.
• The scientific research team has published more than 30 scientific research papers in top international journals in the fields of orthopedics and kinesiology, ultrasound, machine vision and pattern recognition, and has won many international innovation competition awards.
• It has been installed and put into use in 20+ countries and regions, and has established benchmark cases in university research institutions, orthopedics, rehabilitation departments, physical examination departments of hospitals affiliated to the National Health Commission, massage departments of traditional Chinese medicine hospitals, child health care departments of maternal and child health care hospitals, work-related injury rehabilitation hospitals affiliated to the Department of Civil Affairs, sports rehabilitation hospitals affiliated to the Sports Bureau, private orthopedic rehabilitation clinics, traditional Chinese medicine clinics, etc.
• Since its establishment, it has won many international and domestic innovation and entrepreneurship awards: the only winner of the Gold Award in the Guangdong-Hong Kong-Macao Greater Bay Area High-Value Patent Incubation Competition ("GBA") jointly organized by the governments of Guangdong, Hong Kong and Macao in 2023, and the only winner in the field of life and health in the "BOCHK Technology and Innovation Awards" organized by the Hong Kong Alliance for Science and Technology Innovation and sponsored by Bank of China (Hong Kong) Limited in 2022.

About Gobi Ventures (Gobi Greater Bay Area)

Founded in 2016, the Gobi Greater Bay Area is part of Gobi Ventures, a leading pan-Asian venture capital platform. Gobi Greater Bay Area is the manager of Alibaba Hong Kong Entrepreneurs Fund and AEF Greater Bay Area Venture Fund, and has established strategic partnerships with well-known financial institutions such as HSBC and Hang Seng Bank.

As of 2023, the Gobi Greater Bay Area has invested in more than 80 start-ups and successfully nurtured 8 unicorns, including Welab, Airwallex, Amber, and Animoca Brands.